Routine NHS access to spinal muscular atrophy treatments offers new hope for patients and families
Posted:
SMA is a rare, inherited condition that causes progressive muscle weakness, affecting movement, breathing and swallowing. People living with spinal muscular atrophy (SMA) in England are set to gain routine access to two potentially life-changing treatments, following our publication of final draft guidance today.
GIANT Health is delighted to welcome CareLoop to GIANT Health 2026 as part of the NHS Innovation Accelerator (NIA) Pavilion, where the team will demonstrate how remote monitoring is helping people living with severe mental illness remain well in their…
GIANT Health is delighted to welcome RealBirth to GIANT Health 2026, where the team will showcase how digital innovation is helping transform antenatal education and support more equitable maternity care across the NHS.
Access to high-quality antenatal education plays a…
Attendees
Sponsors and Exhibitors
Contact us